KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) Restructuring Costs (2016 - 2023)

Historic Restructuring Costs for Global Medical REIT (GMRE) over the last 9 years, with Q2 2023 value amounting to $2000.0.

  • Global Medical REIT's Restructuring Costs fell 9777.78% to $2000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $44000.0, marking a year-over-year decrease of 8757.06%. This contributed to the annual value of $155000.0 for FY2024, which is 25227.27% up from last year.
  • Global Medical REIT's Restructuring Costs amounted to $2000.0 in Q2 2023, which was down 9777.78% from $42000.0 recorded in Q1 2023.
  • Over the past 5 years, Global Medical REIT's Restructuring Costs peaked at $168000.0 during Q3 2019, and registered a low of $2000.0 during Q2 2023.
  • Its 5-year average for Restructuring Costs is $69647.1, with a median of $62000.0 in 2021.
  • As far as peak fluctuations go, Global Medical REIT's Restructuring Costs surged by 214000.0% in 2022, and later plummeted by 9777.78% in 2023.
  • Over the past 5 years, Global Medical REIT's Restructuring Costs (Quarter) stood at $47000.0 in 2019, then skyrocketed by 108.51% to $98000.0 in 2020, then tumbled by 94.9% to $5000.0 in 2021, then soared by 2140.0% to $112000.0 in 2022, then tumbled by 98.21% to $2000.0 in 2023.
  • Its last three reported values are $2000.0 in Q2 2023, $42000.0 for Q1 2023, and $112000.0 during Q4 2022.